Cargando…

High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities

Background: The prevalence of metabolic and cardiovascular diseases is rising worldwide. However, little is known about the impact of such disorders on hepatic disease progression in chronic hepatitis B (CHB) during the era of potent nucleo(s)tide analogues (NAs). Methods: We retrospectively analyze...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bockmann, Jan-Hendrik, Kohsar, Matin, Murray, John M., Hamed, Vanessa, Dandri, Maura, Lüth, Stefan, Lohse, Ansgar W., Schulze-zur-Wiesch, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146494/ https://www.ncbi.nlm.nih.gov/pubmed/33946154 http://dx.doi.org/10.3390/microorganisms9050968

Ejemplares similares

High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
por: Bockmann, Jan-Hendrik, et al.
Publicado: (2020)

Human hepatitis D virus-specific T cell epitopes
por: Kohsar, Matin, et al.
Publicado: (2021)

Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
por: Ahmadi, Parimah, et al.
Publicado: (2020)

Frequent detection of functional hyposplenism via assessment of pitted erythrocytes in patients with advanced liver cirrhosis
por: Wehmeyer, Malte H., et al.
Publicado: (2022)

The Clinical Perspective on Hepatitis E
por: Horvatits, Thomas, et al.
Publicado: (2019)

Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
por: Pflüger, Lisa Sophie, et al.
Publicado: (2021)

Increased Expression of Complement Regulators CD55 and CD59 on Peripheral Blood Cells in Patients with EAHEC O104:H4 Infection
por: Dammermann, Werner, et al.
Publicado: (2013)

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
por: Karimova, Madina, et al.
Publicado: (2015)

Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients
por: Woo, Marcel S., et al.
Publicado: (2020)

B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19
por: Wildner, Nils H, et al.
Publicado: (2020)

Lower Levels of Transaminases but Higher Levels of Serum Creatinine in Patients with Acute Hepatitis E in Comparison to Patients with Hepatitis A
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).
por: Benten, Daniel, et al.
Publicado: (2011)

Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
por: Heide, Janna, et al.
Publicado: (2021)

Correction: Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
por: Heide, Janna, et al.
Publicado: (2022)

Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients
por: Dammermann, Werner, et al.
Publicado: (2015)

Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection
por: Wehmeyer, Malte H, et al.
Publicado: (2014)

Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct‐Acting Antiviral Treatment Failure in Patients With Hepatitis C?
por: Piecha, Felix, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern
por: Wehmeyer, Malte H., et al.
Publicado: (2016)

Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic
por: Fründt, Thorben, et al.
Publicado: (2021)

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
por: Ruether, Darius F., et al.
Publicado: (2022)

Characterization of the immune cell landscape of patients with NAFLD
por: Diedrich, Tom, et al.
Publicado: (2020)

Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Epigenetic modulation in chronic hepatitis B virus infection
por: Dandri, Maura
Publicado: (2020)

Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection
por: Boesecke, Christoph, et al.
Publicado: (2017)

Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic
por: Engelmann, Petra, et al.
Publicado: (2022)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)

Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease
por: Herrmann, Marissa, et al.
Publicado: (2020)

Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum
por: Kraef, Christian, et al.
Publicado: (2019)

cccDNA Maintenance in Chronic Hepatitis B – Targeting the Matrix of Viral Replication
por: Dandri, Maura, et al.
Publicado: (2020)

Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte
por: Giersch, Katja, et al.
Publicado: (2015)

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
por: Beisel, Claudia, et al.
Publicado: (2014)

Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection
por: Cords, Leon, et al.
Publicado: (2023)

Broadly directed virus-specific CD4(+) T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence
por: Schulze zur Wiesch, Julian, et al.
Publicado: (2012)

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Fründt, Thorben, et al.
Publicado: (2021)

Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice
por: Koop, Anja Christina, et al.
Publicado: (2020)

Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave
por: Herting, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qv1bnbtcolsiei6htnov7q68a8